CASI Pharmaceuticals, Inc (DE) reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
CASI Pharmaceuticals, Inc (DE) has filed 947 SEC EDGAR filings since 14 May 1996

SEC filing history

Showing 26-50 of 580 matching filings.

Per page
25
Current page
2
4

FORM 4 SUBMISSION

Filing date
26 Aug 2022
Reporting date
24 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2022
Reporting date
19 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46247

SC 13D/A

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jun 2022
Reporting date
13 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-20713

DEF 14A

Filing date
15 Apr 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-20713

PRE 14A

Filing date
04 Apr 2022
Reporting date
04 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .